Gene Therapy's Best 25

With PTC Therapeutic’s Kebilidi hitting the market last year, 2025 marks a pivotal moment for drug developers and analytical teams. The successful regulatory approval and commercial success of gene therapies rely heavily on solid clinical data, but even more so on robust assay strategies that suppor...

With PTC Therapeutic’s Kebilidi hitting the market last year, 2025 marks a pivotal moment for drug developers and analytical teams. The successful regulatory approval and commercial success of gene therapies rely heavily on solid clinical data, but even more so on robust assay strategies that support product characterization and regulatory compliance.

• hhhhhhhhhhbbbb
• +1129077777

event link Visit Website Linkedin